A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics
Antimicrobial Agents and Chemotherapy · 18.10.2023 · 67 (10)
DOI: 10.1128/aac.00051-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.10.2023. Verfasst von Jessica D Podoll und 5 weiteren Autor:innen. Beteiligte Einrichtung: Recreo Pharmaceuticals Inc, Yale Circle , Boulder, Colorado, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Novel antibacterial agents and strategies are urgently needed to fight against the ongoing global antibiotic resistance problem. While natural products remain the main source in antibiotic discovery, synthetic antibacterials provide an attractive alternative and may evade the ancient antibiotic resistance. Herein, we report a small molecule that re-sensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics with extremely low potential for resistance development. It belongs to a new class of broad-spectrum antibacterials, trypyricins, which share similar structural characteristics and mechanism of action to the cationic antimicrobial peptides. Mechanistic studies indicated that trypyricins fluidize and disrupt bacterial cytoplasmic membrane. These results suggested that trypyricins represent a promising new class of antibacterials and may be further developed as antibiotic adjuvants to fight against resistant bacteria in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Recreo Pharmaceuticals Inc, Yale Circle , Boulder, Colorado, USA.
- Department of Chemistry, University of Colorado , Boulder, Colorado, USA.
ORCID-Profile: Xiang Wang
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
Zitieren
APA
Podoll, J. D., Rosen, E., Wang, W., Gao, Y., Zhang, J., & Wang, X. (2023). A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy, 67(10). https://doi.org/10.1128/aac.00051-23
Vancouver
Podoll JD, Rosen E, Wang W, Gao Y, Zhang J, Wang X. A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 2023;67(10). doi:10.1128/aac.00051-23
BibTeX
@article{Podoll2023,
author = {Podoll, Jessica D and Rosen, Emma and Wang, Wei and Gao, Yuefeng and Zhang, Jing and Wang, Xiang},
title = {A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {10},
doi = {10.1128/aac.00051-23}
}
EUVIMED